{"id":"NCT05966090","sponsor":"GlaxoSmithKline","briefTitle":"A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults","officialTitle":"A Phase III, Open-label, Randomized, Controlled, Multi-country Study to Evaluate the Immune Response, Safety and Reactogenicity of RSVPreF3 OA Investigational Vaccine When Co-administered With Herpes Zoster Recombinant Subunit (HZ/su) Vaccine in Adults Aged 50 Years and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2023-07-28","primaryCompletion":"2024-02-19","completion":"2024-07-29","firstPosted":"2023-07-28","resultsPosted":"2025-04-01","lastUpdate":"2025-04-01"},"enrollment":530,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Respiratory Syncytial Viruses","Respiratory Syncytial Virus Infections"],"interventions":[{"type":"BIOLOGICAL","name":"RSVPreF3 OA investigational vaccine","otherNames":["Respiratory Syncytial Virus PreFusion protein 3 Older Adults vaccine"]},{"type":"BIOLOGICAL","name":"HZ/su vaccine","otherNames":["Herpes Zoster recombinant subunit vaccine, Shingrix"]}],"arms":[{"label":"Co-administration Group","type":"EXPERIMENTAL"},{"label":"Control Group","type":"ACTIVE_COMPARATOR"}],"summary":"To assess the ability of RSVPreF3 OA investigational vaccine to generate an immune response when given in combination with HZ/su vaccine and its safety in older adults, aged \\>=50 years of age.","primaryOutcome":{"measure":"Adjusted Geometric Mean Concentration (GMC) of Anti-glycoprotein E (gE) Antibodies at 1 Month Post-second Dose of HZ/su Vaccination","timeFrame":"At 1 month post-second dose of HZ/su vaccination (Day 91)","effectByArm":[{"arm":"Co-administration Group","deltaMin":49326.9,"sd":null},{"arm":"Control Group","deltaMin":61192.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":23},"locations":{"siteCount":31,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":265},"commonTop":["Injection site pain","Myalgia","Fatigue","Headache","Chills"]}}